Integrated Core Strategies (US) LLC 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-22 5:32 pm Purchase | 2026-06-16 | 13G | RELMADA THERAPEUTICS INC P RLMD | Integrated Core Strategies (US) LLC | 4,567,952 4.400% | 4,567,952 (New Position) | Filing |